US Edition
COVER-ALL trial highlights superiority of software-based assessment for liver tumour ablation margins - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
COVER-ALL trial highlights superiority of software-based assessment for liver tumour ablation margins - Interventional News
Bruno Odisio New findings from the COVER-ALL trial suggest that software-based assessment of the minimal ablative margin during percutaneous thermal ablation significantly improves treatment precision and may reduce local tumour progression in liver cancer patients. Published in The Lancet Gastroenterology & Hepatology, the randomised phase 2 trial represents the first prospective evaluation of a software-driven margin confirmation method, which…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
